Details for Patent: 10,071,085

Which drugs does patent 10,071,085 protect, and when does it expire?

Patent 10,071,085 protects ONGENTYS and is included in one NDA.

This patent has twenty-seven patent family members in fifteen countries.

Summary for Patent: 10,071,085

Title:	Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof
Abstract:	The present disclosure relates to compositions and pharmaceutical formulations comprising at least one active pharmaceutical ingredient chosen from nitrocatechol derivatives of formula I as defined herein and salts, esters, hydrates, solvates and derivatives thereof and methods of making said compositions and pharmaceutical formulations.
Inventor(s):	de Vasconcelos; Teofilo Cardoso (Sao Mamede do Coronado, PT), dos Santos Lima; Ricardo Jorge (Sao Mamede do Coronado, PT), de Campos Costa; Rui Cerdeira (Sao Mamede do Coronado, PT)
Assignee:	BIAL--Portela & CA, S.A. (Sao Mamede do Coronado, PT)
Application Number:	14/825,600
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Dosage form;

Drugs Protected by US Patent 10,071,085

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Neurocrine	ONGENTYS	opicapone	CAPSULE;ORAL	212489-001	Apr 24, 2020		RX	Yes	No			Y
Neurocrine	ONGENTYS	opicapone	CAPSULE;ORAL	212489-002	Apr 24, 2020		RX	Yes	Yes			Y

International Family Members for US Patent 10,071,085

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2010231961
Brazil	PI1014865
Canada	2757411
China	102448444
China	105878242
Denmark	2413912